Compound Detail
CHEMBL301742
ARBACLOFEN 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL301742 |
| Name | ARBACLOFEN |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | KPYSYYIEGFHWSV-QMMMGPOBSA-N |
5
Targets
13
Activities
2
Assay Types
1
PK Parameters
20
Publications
12
Known Names
3
Indications
1
Mechanisms
Molecular Properties
213.7
MW (Da)
1.86
ALogP
2
HBA
2
HBD
63.3
PSA (Ų)
0.80
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| GABA-B receptor agonist | AGONIST | GABA-B receptor | ✓ | ✓ |
Indications
Child Development Disorders, Pervasive Fragile X Syndrome Muscle Spasticity
Activity Summary
IC50 9 meas. best 7.82
EC50 4 meas. best 7.1
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| GABA-B receptor CHEMBL2111463 | IC50 | 7.82 | 7.82 | 15.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 7.82 | 6.5725 | 15.0 | 4 |
| GABA B receptor CHEMBL2111474 | IC50 | 7.5 | 7.175 | 32.0 | 2 |
| Unchecked CHEMBL612545 | EC50 | 7.1 | 6.2 | 79.4 | 2 |
| Rattus norvegicus CHEMBL376 | IC50 | 6.48 | 6.48 | 330.0 | 1 |
| GABA-B receptor CHEMBL2111463 | EC50 | 6.0 | 6.0 | 1000.0 | 1 |
| Cavia porcellus CHEMBL369 | EC50 | 4.96 | 4.96 | 11000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| T1/2 | 2.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine